Leukemia Drug, 'Nilotinib' Shows Promising Result In Treating Parkinson's and Alzheimer's, Newest Medical Breakthrough for the Past 25 Year!
Parkinson's and Alzheimer's are both brains diseases but medical experts are hoping to see light in a drug called nilotinib. This drug has been approved to treat Philadelphia chromosome-positive chronic myeloid leukemia.
Medical experts suggested that this drug, nilotinib, which has been used patients suffering from leukemia has been linked in curing brain diseases like Parkinson's and Alzheimer as well; What experts foud out that this drug is said to help human's brain to be revitalized and expel the faulty components.
Last 2015, the researchers from Georgetown University Medical Center stirred the hope of the community as they found that small doses of Parkinson's and Alzheimer's. Fernando Pagan, medical director of the translational neurotherapeutics program at Georgetown, described that after releasing that result they are receiving unending phone calls from the public.
According to Dr.Pagan, the leukemia drug, nilotinib did a surprising result with a group of patients with Parkinson's and Alzheimer's that went on a six-month trial. He described that those patients were able to walk without support and the nonverbal patients were able to return to speech.
This leukemia drug, nilotinib works by eliminating the toxic proteins from that are present in the human brain suffering from Parkinson's and Alzheimer's. Pagan said that the mechanism in brain cells that have been activated by the drug works as a garbage disposal.
As of this moment, the main goal of the study is whether this drug, nilotinib, which is originally used to treat patients with leukemia, would be safe enough for patients with Parkinson's and Alzheimer's. But Pagan who studied brain diseases for the past 25 years believed that this is the biggest breakthrough so far.